Literature DB >> 27482614

SERUM LEVELS OF CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH TYPE 2 DIABETES.

Ayman A Zayed, Abdallah M Beano, Farah N Amer, Jumana M Maslamani, Mohammad A Zmaili, Talha H Al-Khudary, Munther S Momani, Al-Motassem F Yousef.   

Abstract

OBJECTIVE: To investigate whether serum carcinoembryonic antigen (CEA) levels are associated with type 2 diabetes mellitus (T2DM) and glycated hemoglobin (HbA1c).
METHODS: A comparative, cross-sectional, observational study was conducted at Jordan University Hospital, Amman, Jordan, on 282 adult subjects from March 2012 to June 2015. Subjects were classified into 2 groups: T2DM subjects (n = 168) and a healthy comparison group (n = 114). Subjects with any condition known to be associated with elevated CEA levels were excluded. HbA1c and serum CEA levels were measured, and body mass index (BMI) was determined.
RESULTS: Subjects with T2DM had significantly higher mean serum CEA than controls (2.4 ± 1.5 vs. 1.5 ± 1.2 ng/mL, P<.0001). Sex did not correlate with CEA levels, while age (Spearman's rho [ρ] = 0.18, P = .002) and HbA1c (ρ = 0.56, P<.0001) did; however, age no longer correlated after correcting for diabetic status. HbA1c was the only variable shown to correlate with CEA in a stepwise linear regression (r = 0 .37, P<.001).
CONCLUSION: We observed a statistically significant association between elevated CEA and T2DM, despite average CEA values for both groups being within the reference range. In addition, serum CEA levels correlated positively with HbA1c values. ABBREVIATIONS: ADA = American Diabetes Association BMI = body mass index CA 19-9 = carbohydrate antigen 19-9 CEA = carcinoembryonic antigen CRP = C-reactive protein DM = diabetes mellitus HbA1c = glycated hemoglobin JUH = Jordan University Hospital T2DM = type 2 diabetes mellitus ρ = Spearman's correlation coefficient.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27482614     DOI: 10.4158/EP161221.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  5 in total

1.  The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control.

Authors:  Xiaojing Shang; Chunqing Song; Xiaoming Du; Hailin Shao; Donghong Xu; Xiaolai Wang
Journal:  Saudi Med J       Date:  2017-02       Impact factor: 1.484

2.  Survival and glycemic control in patients with colorectal cancer and diabetes mellitus.

Authors:  Nina J Karlin; Shailja B Amin; Heidi E Kosiorek; Matthew R Buras; Patricia M Verona; Curtiss B Cook
Journal:  Future Sci OA       Date:  2018-08-15

3.  Synergistic Association of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 on the Risk of Abnormal Glucose Regulation.

Authors:  Yu-Cheng Cheng; Yu-Hsuan Li; Chiann-Yi Hsu; I-Te Lee
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-10       Impact factor: 3.168

4.  High Prevalence of Abnormal Carcinoembryonic Antigen in Diabetic Inpatients with Poor Glycemic Control.

Authors:  Xi-Yu Liu; Chai Jin; Yan Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-04       Impact factor: 3.249

5.  Comment on "Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report".

Authors:  Hiroshi Nomoto; Hideaki Miyoshi; Tomonori Sekizaki; Tatsuya Atsumi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-03-16       Impact factor: 1.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.